RS1303 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"finds no association between rs1303 and pulmonary emphysema [OMIM:PI M3] [GWAS:Metabolite levels]
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Glycogen synthase kinase-3 beta (analyte X3236.12) levels | G | OR: 0.71 | 2E-151 | PubMed |
| ACP5 protein levels | G | β: 0.088 | 3E-56 | PubMed |
| Metabolite levels | — | — | 5E-48 | PubMed |
| Galactokinase levels | G | OR: 0.36 | 4E-40 | PubMed |
| PH and SEC7 domain-containing protein 1 levels (PSD.13055.53.3) | G | OR: 0.36 | 5E-39 | PubMed |
| Cyclin-dependent kinase-like 2 levels | G | OR: 0.4 | 3E-35 | PubMed |
| 39S ribosomal protein L33, mitochondrial levels | G | OR: 0.35 | 8E-35 | PubMed |
| ASPN protein levels | G | β: 0.066 | 3E-25 | PubMed |
| Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | G | β: 0.02 | 1E-24 | PubMed |
| Free cholesterol to total lipids ratio in small HDL | T | β: 0.04 | 9E-19 | PubMed |
| Linoleic acid to total fatty acids percentage | G | β: 0.02 | 4E-17 | PubMed |
| Asporin levels | T | OR: 0.12 | 6E-17 | PubMed |
| Free cholesterol to total lipids ratio in small VLDL | T | β: 0.038 | 7E-17 | PubMed |
| Cholesteryl esters to total lipids ratio in large VLDL | T | β: 0.036 | 5E-15 | PubMed |
| Cas scaffolding protein family member 4 levels | G | OR: 0.2 | 1E-13 | PubMed |
| mRNA-decapping enzyme 1B levels | G | OR: 0.2 | 2E-13 | PubMed |
| Monounsaturated fatty acids to total fatty acids percentage | G | β: 0.02 | 5E-13 | PubMed |
| Phospholipids to total lipids ratio in small HDL | T | β: 0.033 | 6E-13 | PubMed |
| FSTL1 protein levels | G | β: 0.048 | 7E-13 | PubMed |
| Cholesteryl esters to total lipids ratio in medium VLDL | T | β: 0.032 | 7E-13 | PubMed |